Webinar
Accelerating preclinical assessment
Using artificial intelligence for the quantitative assessment of alpha-synuclein pathology
Topics discussed:
- Developing AI models with Aiforia Create for quantifying alpha-synuclein in brain tissue
- Benefits of using deep learning AI in preclinical analysis
- Introduction and live demo of Aiforia
Speakers
Pekka Kallunki PhD
Principal Scientist at Lundbeck A/S
Hanna-Kaisa Sihvo DVM PhD Dipl ECVP
Senior Scientist at Aiforia